- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07644689
Triple-Scan Protocol to Assess Passivity
Triple-Scan Protocol for Evaluating Passivity of Complete-Arch Implant-Supported Fixed Prostheses: A Randomized Clinical Study
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Al Mansurah, Egypt
- Alaa Mohamed Barakat Elazaly
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Reduced patient satisfaction regarding the stability and retention of conventional mandibular dentures due to mandibular ridge atrophy.
Completely edentulous maxillary and mandibular arches for at least 1 year. Sufficient bone volume for placement of four mandibular implants without the need for bone grafting.
Age between 45 and 64 years. Ability and willingness to provide informed consent and comply with study procedures.
Exclusion Criteria:
Current smoking habit. Bone metabolic diseases that may affect osseointegration. History of radiotherapy to the head and neck region within the previous 3 years.
Systemic conditions or medications that could compromise implant healing. Inability to attend follow-up visits or comply with study requirements.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Sequence A
Participants received the three impression techniques in the following order: Conventional Impression Technique Digital Impression with Nonmodified Scan Body Digital Impression with Modified Scan Body |
Conventional implant impression using impression copings and elastomeric impression material.
Digital implant impression obtained using nonmodified implant scan bodies
Digital implant impression obtained using subtractively modified implant scan bodies
|
|
Active Comparator: Sequence B
Participants received the three impression techniques in the following order: Digital Impression with Nonmodified Scan Body Digital Impression with Modified Scan Body Conventional Impression Technique |
Conventional implant impression using impression copings and elastomeric impression material.
Digital implant impression obtained using nonmodified implant scan bodies
Digital implant impression obtained using subtractively modified implant scan bodies
|
|
Active Comparator: Sequence C
Participants received the three impression techniques in the following order: Digital Impression with Modified Scan Body Conventional Impression Technique Digital Impression with Nonmodified Scan Body |
Conventional implant impression using impression copings and elastomeric impression material.
Digital implant impression obtained using nonmodified implant scan bodies
Digital implant impression obtained using subtractively modified implant scan bodies
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean horizontal misfit (µm)
Time Frame: Day 1
|
Mean horizontal misfit using the triple-scan protocol and STL file superimposition in software.
Results will be reported in micrometers (µm).
|
Day 1
|
|
Mean vertical misfit (µm)
Time Frame: Day 1
|
Mean vertical misfit using the triple-scan protocol and STL file superimposition in software.
Results will be reported in micrometers (µm).
|
Day 1
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- R.25.09.24
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostheses Durability
-
Liberating Technologies, Inc.CompletedOrthoses | ProsthesesUnited States
-
Istituto Ortopedico RizzoliCompletedProstheses and ImplantsItaly
-
Nottingham Trent UniversityCompleted
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingHealthy Volunteers | Prostheses | AmputeeFrance
-
University of MichiganUnited States Department of DefenseRecruitingAmputation | Prostheses and ImplantsUnited States
-
Ain Shams UniversityCompletedMandibular Distal-extension ProsthesesEgypt
-
Damascus UniversityCompletedMandibular Distal-extension ProsthesesSyrian Arab Republic
-
Cairo UniversityNot yet recruitingProstheses | Endosseous Dental Implant FailureEgypt
-
Maastricht University Medical CenterUnknownProstheses and Implants | Craniofacial DefectsNetherlands
Clinical Trials on Conventional Impression Technique
-
University of FlorenceCompleted
-
Cairo UniversityCompletedDiabetes Free Completely Edentulous PatientsEgypt
-
Alexandria UniversityCompleted
-
Cairo UniversityNot yet recruitingPassivity | Prosthetic Complications
-
Mansoura UniversityCompleted
-
Shanghai Ninth People's Hospital Affiliated to...Enrolling by invitationEdentulous JawChina
-
Mirna ashraf anis heneenRecruitingEdentulous Jaw | Dental Implantation, Endosseous | Prosthodontics | Dental Prosthesis, Implant-SupportedEgypt
-
Aga Khan UniversityNot yet recruitingPatient Satisfaction | Denture Retention
-
Aldent UniversityCompletedComplete EdentulismAlbania
-
Mansoura UniversityRecruiting